Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer

BACKGROUND: The human epidermal growth factor receptor 2 (HER2) and p53 pathways may be involved in chemotherapy sensitivity and/or resistance. We explore the value of HER2 and p53 status to foretell docetaxel sensitivity in advanced breast cancer. METHODS: HER2 and p53 expression was analysed in 36...

Descripción completa

Detalles Bibliográficos
Autores principales: Camerini, Andrea, Donati, Sara, Viacava, Paolo, Siclari, Olimpia, Puccetti, Cheti, Tartarelli, Gianna, Valsuani, Chiara, De Luca, Filomena, Martini, Leonardo, Cavazzana, Andrea, Amoroso, Domenico
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080331/
https://www.ncbi.nlm.nih.gov/pubmed/21481270
http://dx.doi.org/10.1186/1756-9966-30-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080331/
https://www.ncbi.nlm.nih.gov/pubmed/21481270
http://dx.doi.org/10.1186/1756-9966-30-38

Ejemplares similares